PIERAGNOLI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.372
EU - Europa 1.226
AS - Asia 351
AF - Africa 9
OC - Oceania 1
SA - Sud America 1
Totale 3.960
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.369
RU - Federazione Russa 605
IE - Irlanda 164
PL - Polonia 146
IT - Italia 141
SE - Svezia 110
SG - Singapore 105
HK - Hong Kong 104
CN - Cina 79
JO - Giordania 33
FI - Finlandia 26
IN - India 17
DE - Germania 15
CI - Costa d'Avorio 8
VN - Vietnam 8
UA - Ucraina 7
CA - Canada 3
GB - Regno Unito 3
BE - Belgio 2
FR - Francia 2
NL - Olanda 2
PT - Portogallo 2
TR - Turchia 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
JP - Giappone 1
KG - Kirghizistan 1
MU - Mauritius 1
PK - Pakistan 1
Totale 3.960
Salva come PNG Salva come JPEG
Città #
Santa Clara 487
Fairfield 307
Ashburn 173
Dublin 164
Seattle 150
Warsaw 146
Woodbridge 146
Chandler 142
Cambridge 118
Houston 111
Singapore 91
Wilmington 89
Hong Kong 70
Lawrence 52
Altamura 50
Ann Arbor 49
Princeton 37
Buffalo 35
Beijing 29
Boston 27
Kent 22
Florence 21
San Diego 21
Jacksonville 18
Medford 18
Mumbai 15
Shanghai 14
Moscow 13
Falls Church 10
New York 9
Norwalk 9
Abidjan 8
Boardman 7
Milan 7
Yubileyny 5
Campi Bisenzio 4
Dong Ket 4
Munich 4
West Jordan 4
Boydton 3
Guangzhou 3
Los Angeles 3
Phoenix 3
Andover 2
Brussels 2
Capergnanica 2
Cesano Boscone 2
Cesena 2
Cosenza 2
Helsinki 2
London 2
Orenburg 2
Paris 2
Poggibonsi 2
Porto 2
Pune 2
Scarperia e San Piero 2
Terni 2
Trinitapoli 2
Washington 2
Anzio 1
Bern 1
Bishkek 1
Brescia 1
Islamabad 1
Izmir 1
Jinan 1
Laurel 1
Leawood 1
Lecce 1
Marsicovetere 1
Massa E Cozzile 1
Montréal 1
Nanchang 1
Naples 1
Negrar 1
Philadelphia 1
Redwood City 1
Rome 1
Rui'an 1
Saga 1
Saint Paul 1
Samarate 1
Senago 1
Shenzhen 1
São Paulo 1
Taicang 1
Toronto 1
Turin 1
Totale 2.761
Salva come PNG Salva come JPEG
Nome #
Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology 173
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 142
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 134
Effects of smoking in patients treated with cardiac resynchronization therapy 131
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 125
Management of antithrombotic therapy in patients undergoing electrophysiological device surgery 120
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 120
Left ventricular mass and progenitor cells in chronic heart failure patients 118
Sleep Disordered Breathing and Arrhythmia Burden in Pacemaker Recipients 116
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 116
A contribution for validation of ECG criteria for interatrial conduction delay. 113
Larger interventricular conduction time enhances mechanical response to resynchronization therapy 112
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 112
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 112
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 111
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 111
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 108
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 108
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 107
Multicenter experience with implantable defibrillators subject to recall. 106
The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association 106
Dual-site left ventricular cardiac resynchronization therapy. 105
Persistent atrial fibrillation in the elderly. A possible association with arterial stiffness, hyperuricemia and chronic inflammation 104
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 104
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 103
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 102
Atrial standstill disease progression documented after 13 years follow-up 97
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 95
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 91
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 89
Incidence of ventricular arrhythmias after biventricular defibrillator replacement: impact on safety of downgrading from CRT-D to CRT-P 80
Patients' knowledge and attitudes regarding living with implantable electronic devices: Results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association 79
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 79
Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. 73
P3212 The effect of age on quality of life in patients with cardiac implantable electronic devices. The results of an EHRA Scientific Initiatives Committee multinational survey in Italian patients 60
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy 53
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 52
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 52
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 48
Tricuspid annular plane systolic excursion evaluation improves selection of cardiac resynchronization therapy patients 42
Totale 4.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 0 0 0 78 77 80 84 73 50 46 13
2020/2021322 32 32 14 45 14 23 19 35 29 41 20 18
2021/2022279 9 13 21 7 11 17 17 17 19 11 61 76
2022/2023706 58 169 39 28 34 107 112 52 71 5 24 7
2023/2024332 6 35 42 15 28 55 18 85 5 11 26 6
2024/20251.364 74 182 124 382 602 0 0 0 0 0 0 0
Totale 4.009